Corona Remedies to host JP Morgan-led analyst meet on Sep 23

scanx
Reviewed by
Shriram SScanX News Team
Key Highlights
  • Corona Remedies to hold analyst meet on Sep 23, 2026
  • Session organized by JP Morgan in Ahmedabad at 2:00 pm
  • Discussions limited to publicly available information
  • No unpublished price-sensitive information to be shared
powered bylight_fuzz_icon
51270046

*this image is generated using AI for illustrative purposes only.

Corona Remedies will host a group meeting with analysts and investors on September 23, 2026. The session is scheduled for 2:00 pm in Ahmedabad and will be organized by JP Morgan.

The company disclosed the schedule pursuant to Regulation 30 read with Schedule III of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015.

Meeting Details

The interaction will focus on publicly available information. The company stated that no unpublished price-sensitive information (UPSI) is intended to be discussed during the event.

Day, Date & Time Organized By Nature of Meeting Place
Wednesday, September 23, 2026, 2:00 pm JP Morgan Group Meeting Ahmedabad

Chetna Dharajiya, Company Secretary and Compliance Officer, signed the intimation filed with the Bombay Stock Exchange and the National Stock Exchange of India Limited. The notice was issued on September 18, 2026.

The company noted that changes to the schedule may occur due to exigencies on the part of the host or the company. The intimation is also available on the company's website.

Historical Stock Returns for Corona Remedies

1 Day5 Days1 Month6 Months1 Year5 Years
+1.48%+0.05%+4.20%+41.05%+53.07%+53.07%

What specific operational or financial metrics is JP Morgan likely to prioritize in their analysis of Corona Remedies during this group meeting?

How might the market react to Corona Remedies' stock price if no new strategic initiatives are disclosed during this compliance-driven session?

Are there any upcoming regulatory changes in India's pharmaceutical sector that could influence the agenda of this September 2026 investor interaction?

Corona Remedies to hold analyst and investor meeting on August 26

scanx
Reviewed by
Ashish TScanX News Team
Key Highlights
  • Corona Remedies to host analyst and investor meeting on August 26
  • Event organized by Phillip Capital PCG in Ahmedabad
  • Discussions limited to publicly available information only
  • No UPSI will be discussed per SEBI regulations
powered bylight_fuzz_icon
48772815

*this image is generated using AI for illustrative purposes only.

Corona Remedies Limited confirmed that its officials will attend an analyst and investor meeting organized by Phillip Capital PCG. The session is scheduled for Wednesday, August 26, 2026, at 11:00 am in Ahmedabad.

The company stated that discussions during the group meeting will be restricted to publicly available information. No unpublished price sensitive information (UPSI) will be shared, adhering to Regulation 30 read with Schedule III of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.

Event Details

Parameter Details
Date and Time August 26, 2026, 11:00 am onwards
Organizer Phillip Capital PCG
Nature Group Meeting
Mode In-Person
Location Ahmedabad

Chetna Dharajiya, Company Secretary and Compliance Officer, issued the intimation on August 20, 2026. The company noted that schedule changes may occur due to exigencies from the host or the company. This disclosure is also available on the company’s website.

Historical Stock Returns for Corona Remedies

1 Day5 Days1 Month6 Months1 Year5 Years
+1.48%+0.05%+4.20%+41.05%+53.07%+53.07%

How might the insights shared at this analyst meeting influence Corona Remedies' stock valuation in the immediate quarter following August 2026?

What specific growth strategies or operational updates is Phillip Capital PCG likely to probe regarding Corona Remedies' pipeline and market expansion?

Could this meeting signal an upcoming strategic shift or partnership announcement for Corona Remedies in the near future?

More News on Corona Remedies

1 Year Returns:+53.07%